<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2016-04-13" version="211">
<accession>P04156</accession>
<accession>O60489</accession>
<accession>P78446</accession>
<accession>Q15216</accession>
<accession>Q15221</accession>
<accession>Q27H91</accession>
<accession>Q5QPB4</accession>
<accession>Q8TBG0</accession>
<accession>Q96E70</accession>
<accession>Q9UP19</accession>
<name>PRIO_HUMAN</name>
<protein>
<recommendedName>
<fullName>Major prion protein</fullName>
<shortName>PrP</shortName>
</recommendedName>
<alternativeName>
<fullName>ASCR</fullName>
</alternativeName>
<alternativeName>
<fullName>PrP27-30</fullName>
</alternativeName>
<alternativeName>
<fullName>PrP33-35C</fullName>
</alternativeName>
<cdAntigenName>CD230</cdAntigenName>
</protein>
<gene>
<name type="primary">PRNP</name>
<name type="synonym">ALTPRP</name>
<name type="synonym">PRIP</name>
<name type="synonym">PRP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="DNA" volume="5" first="315" last="324">
<title>Molecular cloning of a human prion protein cDNA.</title>
<authorList>
<person name="Kretzschmar H.A."/>
<person name="Stowring L.E."/>
<person name="Westaway D."/>
<person name="Stubblebine W.H."/>
<person name="Prusiner S.B."/>
<person name="Dearmond S.J."/>
</authorList>
<dbReference type="PubMed" id="3755672"/>
<dbReference type="DOI" id="10.1089/dna.1986.5.315"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Am. J. Hum. Genet." volume="49" first="320" last="329">
<title>Genomic structure of the human prion protein gene.</title>
<authorList>
<person name="Puckett C."/>
<person name="Concannon P."/>
<person name="Casey C."/>
<person name="Hood L.E."/>
</authorList>
<dbReference type="PubMed" id="1678248"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT 56-GLY--GLY-63 DEL</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Genome Res." volume="8" first="1022" last="1037">
<title>Complete genomic sequence and analysis of the prion protein gene region from three mammalian species.</title>
<authorList>
<person name="Lee I.Y."/>
<person name="Westaway D."/>
<person name="Smit A.F.A."/>
<person name="Wang K."/>
<person name="Seto J."/>
<person name="Chen L."/>
<person name="Acharya C."/>
<person name="Ankener M."/>
<person name="Baskin D."/>
<person name="Cooper C."/>
<person name="Yao H."/>
<person name="Prusiner S.B."/>
<person name="Hood L.E."/>
</authorList>
<dbReference type="PubMed" id="9799790"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Am. J. Med. Genet." volume="88" first="653" last="656">
<title>Novel PRNP sequence variant associated with familial encephalopathy.</title>
<authorList>
<person name="Cervenakova L."/>
<person name="Buetefisch C."/>
<person name="Lee H.S."/>
<person name="Taller I."/>
<person name="Stone G."/>
<person name="Gibbs C.J. Jr."/>
<person name="Brown P."/>
<person name="Hallett M."/>
<person name="Goldfarb L.G."/>
</authorList>
<dbReference type="PubMed" id="10581485"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19991215)88:6&lt;653::AID-AJMG14>3.0.CO;2-E"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT GSD ARG-187</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2000-09" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human prostate prion protein cDNA.</title>
<authorList>
<person name="Hryb D.J."/>
<person name="Reynolds T.A."/>
<person name="Nakhla A.M."/>
<person name="Kahn S.M."/>
<person name="Khan S.M."/>
<person name="Romas N.A."/>
<person name="Rosner W."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2006-02" db="EMBL/GenBank/DDBJ databases">
<title>Analysis and comparison of several mammalian prion protein genes Prnp.</title>
<authorList>
<person name="Zhang J."/>
<person name="Liu Y."/>
<person name="Chen H."/>
<person name="Jiang H."/>
<person name="Lu W."/>
<person name="Zhu X."/>
<person name="Xie Q."/>
<person name="Cai X."/>
<person name="Liu X."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1986" name="Science" volume="233" first="364" last="367">
<title>Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications.</title>
<authorList>
<person name="Liao Y.-C.J."/>
<person name="Lebo R.V."/>
<person name="Clawson G.A."/>
<person name="Smuckler E.A."/>
</authorList>
<dbReference type="PubMed" id="3014653"/>
<dbReference type="DOI" id="10.1126/science.3014653"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 8-253</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1992" name="Hum. Mol. Genet." volume="1" first="443" last="444">
<title>Deletion in the prion protein gene in a demented patient.</title>
<authorList>
<person name="Diedrich J.F."/>
<person name="Knopman D.S."/>
<person name="List J.F."/>
<person name="Olson K."/>
<person name="Frey W.H."/>
<person name="Emory C.R."/>
<person name="Sung J.H."/>
<person name="Haase A.T."/>
</authorList>
<dbReference type="PubMed" id="1363802"/>
<dbReference type="DOI" id="10.1093/hmg/1.6.443"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-232</scope>
<scope>VARIANT 56-GLY--GLY-63 DEL</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Nature" volume="390" first="241" last="241">
<title>A prion-linked psychiatric disorder.</title>
<authorList>
<person name="Samaia H.B."/>
<person name="Mari J.J."/>
<person name="Vallada H.P."/>
<person name="Moura R.P."/>
<person name="Simpson A.J.G."/>
<person name="Brentani R.R."/>
</authorList>
<dbReference type="PubMed" id="9384372"/>
<dbReference type="DOI" id="10.1038/36757"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-253</scope>
<scope>VARIANT SCHIZOAFFECTIVE DISORDER SER-171</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="Am. J. Med. Genet." volume="60" first="12" last="18">
<title>SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease family.</title>
<authorList>
<person name="Perry R.T."/>
<person name="Go R.C."/>
<person name="Harrell L.E."/>
<person name="Acton R.T."/>
</authorList>
<dbReference type="PubMed" id="7485229"/>
<dbReference type="DOI" id="10.1002/ajmg.1320600104"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-85</scope>
<scope>VARIANT 56-GLY--GLY-63 DEL</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="EMBO J." volume="10" first="513" last="519">
<title>Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.</title>
<authorList>
<person name="Tagliavini F."/>
<person name="Prelli F."/>
<person name="Ghiso J."/>
<person name="Bugiani O."/>
<person name="Serban D."/>
<person name="Prusiner S.B."/>
<person name="Farlow M.R."/>
<person name="Ghetti B."/>
<person name="Frangione B."/>
</authorList>
<dbReference type="PubMed" id="1672107"/>
</citation>
<scope>PROTEIN SEQUENCE OF 58-85 AND 111-150</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="10926" last="10930">
<title>Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene.</title>
<authorList>
<person name="Goldfarb L.G."/>
<person name="Brown P."/>
<person name="McCombie W.R."/>
<person name="Goldgaber D."/>
<person name="Swergold G.D."/>
<person name="Wills P.R."/>
<person name="Cervenakova L."/>
<person name="Baron H."/>
<person name="Gibbs C.J. Jr."/>
<person name="Gajdusek D.C."/>
</authorList>
<dbReference type="PubMed" id="1683708"/>
<dbReference type="DOI" id="10.1073/pnas.88.23.10926"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 84-91</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Am. J. Hum. Genet." volume="63" first="1431" last="1438">
<title>A Huntington disease-like neurodegenerative disorder maps to chromosome 20p.</title>
<authorList>
<person name="Xiang F."/>
<person name="Almqvist E.W."/>
<person name="Huq M."/>
<person name="Lundin A."/>
<person name="Hayden M.R."/>
<person name="Edstroem L."/>
<person name="Anvret M."/>
<person name="Zhang Z."/>
</authorList>
<dbReference type="PubMed" id="9792871"/>
<dbReference type="DOI" id="10.1086/302093"/>
</citation>
<scope>INVOLVEMENT IN HDL1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="38956" last="38965">
<title>Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate.</title>
<authorList>
<person name="Mani K."/>
<person name="Cheng F."/>
<person name="Havsmark B."/>
<person name="Jonsson M."/>
<person name="Belting M."/>
<person name="Fransson L.A."/>
</authorList>
<dbReference type="PubMed" id="12732622"/>
<dbReference type="DOI" id="10.1074/jbc.M300394200"/>
</citation>
<scope>COPPER-BINDING</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="J. Alzheimers Dis." volume="2" first="27" last="35">
<title>The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein.</title>
<authorList>
<person name="Capellari S."/>
<person name="Zaidi S.I."/>
<person name="Long A.C."/>
<person name="Kwon E.E."/>
<person name="Petersen R.B."/>
</authorList>
<dbReference type="PubMed" id="12214108"/>
</citation>
<scope>GLYCOSYLATION AT ASN-181</scope>
<scope>VARIANT SENF ALA-183</scope>
<scope>CHARACTERIZATION OF VARIANT SENF ALA-183</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Am. Chem. Soc." volume="127" first="12647" last="12656">
<title>The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4.</title>
<authorList>
<person name="Chattopadhyay M."/>
<person name="Walter E.D."/>
<person name="Newell D.J."/>
<person name="Jackson P.J."/>
<person name="Aronoff-Spencer E."/>
<person name="Peisach J."/>
<person name="Gerfen G.J."/>
<person name="Bennett B."/>
<person name="Antholine W.E."/>
<person name="Millhauser G.L."/>
</authorList>
<dbReference type="PubMed" id="16144413"/>
<dbReference type="DOI" id="10.1021/ja053254z"/>
</citation>
<scope>COPPER-BINDING</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Am. Chem. Soc." volume="129" first="15440" last="15441">
<title>The prion protein is a combined zinc and copper binding protein: Zn2+ alters the distribution of Cu2+ coordination modes.</title>
<authorList>
<person name="Walter E.D."/>
<person name="Stevens D.J."/>
<person name="Visconte M.P."/>
<person name="Millhauser G.L."/>
</authorList>
<dbReference type="PubMed" id="18034490"/>
<dbReference type="DOI" id="10.1021/ja077146j"/>
</citation>
<scope>COPPER-BINDING</scope>
<scope>ZINC-BINDING</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="2787" last="2794">
<title>Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation.</title>
<authorList>
<person name="Juanes M.E."/>
<person name="Elvira G."/>
<person name="Garcia-Grande A."/>
<person name="Calero M."/>
<person name="Gasset M."/>
</authorList>
<dbReference type="PubMed" id="19059915"/>
<dbReference type="DOI" id="10.1074/jbc.M804051200"/>
</citation>
<scope>ALTERNATIVE INITIATION (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF MET-1 AND MET-8</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-197</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="PLoS Pathog." volume="5" first="E1000666" last="E1000666">
<title>Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.</title>
<authorList>
<person name="Taylor D.R."/>
<person name="Whitehouse I.J."/>
<person name="Hooper N.M."/>
</authorList>
<dbReference type="PubMed" id="19936054"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000666"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DISEASE ASSOCIATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="PLoS Pathog." volume="5" first="E1000390" last="E1000390">
<title>Early onset prion disease from octarepeat expansion correlates with copper or zinc binding properties.</title>
<authorList>
<person name="Stevens D.J."/>
<person name="Walter E.D."/>
<person name="Rodriguez A."/>
<person name="Draper D."/>
<person name="Davies P."/>
<person name="Brown D.R."/>
<person name="Millhauser G.L."/>
</authorList>
<dbReference type="PubMed" id="19381258"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000390"/>
</citation>
<scope>COPPER-BINDING</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="21004" last="21012">
<title>Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3.</title>
<authorList>
<person name="Adrover M."/>
<person name="Pauwels K."/>
<person name="Prigent S."/>
<person name="de Chiara C."/>
<person name="Xu Z."/>
<person name="Chapuis C."/>
<person name="Pastore A."/>
<person name="Rezaei H."/>
</authorList>
<dbReference type="PubMed" id="20375014"/>
<dbReference type="DOI" id="10.1074/jbc.M110.111815"/>
</citation>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="J. Cell. Biochem." volume="111" first="627" last="633">
<title>Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment.</title>
<authorList>
<person name="Wu D."/>
<person name="Zhang W."/>
<person name="Luo Q."/>
<person name="Luo K."/>
<person name="Huang L."/>
<person name="Wang W."/>
<person name="Huang T."/>
<person name="Chen R."/>
<person name="Lin Y."/>
<person name="Pang D."/>
<person name="Xiao G."/>
</authorList>
<dbReference type="PubMed" id="20564047"/>
<dbReference type="DOI" id="10.1002/jcb.22743"/>
</citation>
<scope>COPPER-BINDING</scope>
<scope>CIRCULAR DICHROISM</scope>
<scope>DOMAIN</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="FASEB J." volume="25" first="2373" last="2386">
<title>An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein.</title>
<authorList>
<person name="Vanderperre B."/>
<person name="Staskevicius A.B."/>
<person name="Tremblay G."/>
<person name="McCoy M."/>
<person name="O'Neill M.A."/>
<person name="Cashman N.R."/>
<person name="Roucou X."/>
</authorList>
<dbReference type="PubMed" id="21478263"/>
<dbReference type="DOI" id="10.1096/fj.10-173815"/>
</citation>
<scope>BICISTRONIC GENE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Mol. Cell. Biochem." volume="350" first="127" last="134">
<title>Characterizing the novel protein p33MONOX.</title>
<authorList>
<person name="Mishra M."/>
<person name="Inoue N."/>
<person name="Heese K."/>
</authorList>
<dbReference type="PubMed" id="21153684"/>
<dbReference type="DOI" id="10.1007/s11010-010-0690-4"/>
</citation>
<scope>INTERACTION WITH KIAA1191</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="33650" last="33654">
<title>Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Swietnicki W."/>
<person name="Zagorski M.G."/>
<person name="Surewicz W.K."/>
<person name="Soennichsen F.D."/>
</authorList>
<dbReference type="PubMed" id="10954699"/>
<dbReference type="DOI" id="10.1074/jbc.C000483200"/>
</citation>
<scope>STRUCTURE BY NMR OF 90-231 OF MUTANT LYS-200</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="145" last="150">
<title>NMR solution structure of the human prion protein.</title>
<authorList>
<person name="Zahn R."/>
<person name="Liu A."/>
<person name="Luhrs T."/>
<person name="Riek R."/>
<person name="von Schroetter C."/>
<person name="Lopez Garcia F."/>
<person name="Billeter M."/>
<person name="Calzolai L."/>
<person name="Wider G."/>
<person name="Wuethrich K."/>
</authorList>
<dbReference type="PubMed" id="10618385"/>
<dbReference type="DOI" id="10.1073/pnas.97.1.145"/>
</citation>
<scope>STRUCTURE BY NMR OF 23-230</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="8340" last="8345">
<title>NMR structures of three single-residue variants of the human prion protein.</title>
<authorList>
<person name="Calzolai L."/>
<person name="Lysek D.A."/>
<person name="Guntert P."/>
<person name="von Schroetter C."/>
<person name="Riek R."/>
<person name="Zahn R."/>
<person name="Wuethrich K."/>
</authorList>
<dbReference type="PubMed" id="10900000"/>
<dbReference type="DOI" id="10.1073/pnas.97.15.8340"/>
</citation>
<scope>STRUCTURE BY NMR OF 118-221</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="770" last="774">
<title>Crystal structure of the human prion protein reveals a mechanism for oligomerization.</title>
<authorList>
<person name="Knaus K.J."/>
<person name="Morillas M."/>
<person name="Swietnicki W."/>
<person name="Malone M."/>
<person name="Surewicz W.K."/>
<person name="Yee V.C."/>
</authorList>
<dbReference type="PubMed" id="11524679"/>
<dbReference type="DOI" id="10.1038/nsb0901-770"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 119-226</scope>
<scope>DOMAIN</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="3991" last="4001">
<title>Molecular features of the copper binding sites in the octarepeat domain of the prion protein.</title>
<authorList>
<person name="Burns C.S."/>
<person name="Aronoff-Spencer E."/>
<person name="Dunham C.M."/>
<person name="Lario P."/>
<person name="Avdievich N.I."/>
<person name="Antholine W.E."/>
<person name="Olmstead M.M."/>
<person name="Vrielink A."/>
<person name="Gerfen G.J."/>
<person name="Peisach J."/>
<person name="Scott W.G."/>
<person name="Millhauser G.L."/>
</authorList>
<dbReference type="PubMed" id="11900542"/>
<dbReference type="DOI" id="10.1021/bi011922x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (0.75 ANGSTROMS) OF 61-65 IN COMPLEX WITH COPPER ION</scope>
<scope>DOMAIN</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="J. Mol. Biol." volume="334" first="477" last="488">
<title>The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site.</title>
<authorList>
<person name="Zahn R."/>
</authorList>
<dbReference type="PubMed" id="14623188"/>
<dbReference type="DOI" id="10.1016/j.jmb.2003.09.048"/>
</citation>
<scope>STRUCTURE BY NMR OF 61-68</scope>
<scope>DISULFIDE BOND</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1993" name="Hum. Mutat." volume="2" first="168" last="173">
<title>Mutations and polymorphisms in the prion protein gene.</title>
<authorList>
<person name="Palmer M.S."/>
<person name="Collinge J."/>
</authorList>
<dbReference type="PubMed" id="8364585"/>
<dbReference type="DOI" id="10.1002/humu.1380020303"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1993" name="Arch. Neurol." volume="50" first="1129" last="1153">
<title>Genetic and infectious prion diseases.</title>
<authorList>
<person name="Prusiner S.B."/>
</authorList>
<dbReference type="PubMed" id="8105771"/>
<dbReference type="DOI" id="10.1001/archneur.1993.00540110011002"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
<scope>INVOLVEMENT IN PRION DISEASES</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Nature" volume="447" first="453" last="457">
<title>Atomic structures of amyloid cross-beta spines reveal varied steric zippers.</title>
<authorList>
<person name="Sawaya M.R."/>
<person name="Sambashivan S."/>
<person name="Nelson R."/>
<person name="Ivanova M.I."/>
<person name="Sievers S.A."/>
<person name="Apostol M.I."/>
<person name="Thompson M.J."/>
<person name="Balbirnie M."/>
<person name="Wiltzius J.J."/>
<person name="McFarlane H.T."/>
<person name="Madsen A.O."/>
<person name="Riekel C."/>
<person name="Eisenberg D."/>
</authorList>
<dbReference type="PubMed" id="17468747"/>
<dbReference type="DOI" id="10.1038/nature05695"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 170-175</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="2554" last="2558">
<title>Crystal structure of human prion protein bound to a therapeutic antibody.</title>
<authorList>
<person name="Antonyuk S.V."/>
<person name="Trevitt C.R."/>
<person name="Strange R.W."/>
<person name="Jackson G.S."/>
<person name="Sangar D."/>
<person name="Batchelor M."/>
<person name="Cooper S."/>
<person name="Fraser C."/>
<person name="Jones S."/>
<person name="Georgiou T."/>
<person name="Khalili-Shirazi A."/>
<person name="Clarke A.R."/>
<person name="Hasnain S.S."/>
<person name="Collinge J."/>
</authorList>
<dbReference type="PubMed" id="19204296"/>
<dbReference type="DOI" id="10.1073/pnas.0809170106"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 119-231 IN COMPLEX WITH FAB FRAGMENT OF MONOCLONAL ANTIBODY ICSM 18</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="251" last="262">
<title>Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.</title>
<authorList>
<person name="Lee S."/>
<person name="Antony L."/>
<person name="Hartmann R."/>
<person name="Knaus K.J."/>
<person name="Surewicz K."/>
<person name="Surewicz W.K."/>
<person name="Yee V.C."/>
</authorList>
<dbReference type="PubMed" id="19927125"/>
<dbReference type="DOI" id="10.1038/emboj.2009.333"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 125-227 OF VARIANT VAL-129</scope>
<scope>VARIANT VAL-129</scope>
<scope>VARIANT CJD ASN-178</scope>
<scope>VARIANT FFI ASN-178</scope>
<scope>VARIANT GSD SER-198</scope>
<scope>SUBUNIT</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1989" name="Nature" volume="338" first="342" last="345">
<title>Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome.</title>
<authorList>
<person name="Hsiao K."/>
<person name="Baker H.F."/>
<person name="Crow T.J."/>
<person name="Poulter M."/>
<person name="Owen F."/>
<person name="Terwilliger J.D."/>
<person name="Westaway D."/>
<person name="Ott J."/>
<person name="Pursiner S.B."/>
</authorList>
<dbReference type="PubMed" id="2564168"/>
<dbReference type="DOI" id="10.1038/338342a0"/>
</citation>
<scope>VARIANT GSD LEU-102</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="163" first="974" last="979">
<title>Pro-->Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome.</title>
<authorList>
<person name="Doh-Ura K."/>
<person name="Tateishi J."/>
<person name="Sasaki H."/>
<person name="Kitamoto T."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="2783132"/>
<dbReference type="DOI" id="10.1016/0006-291X(89)92317-6"/>
</citation>
<scope>VARIANTS LEU-102; VAL-117 AND VAL-129</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1992" name="Neurology" volume="42" first="669" last="670">
<title>Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.</title>
<authorList>
<person name="Medori R."/>
<person name="Montagna P."/>
<person name="Tritschler H.J."/>
<person name="Leblanc A."/>
<person name="Cortelli P."/>
<person name="Tinuper P."/>
<person name="Lugaresi E."/>
<person name="Gambetti P."/>
</authorList>
<dbReference type="PubMed" id="1347910"/>
<dbReference type="DOI" id="10.1212/WNL.42.3.669"/>
</citation>
<scope>VARIANT FFI ASN-178</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1991" name="Lancet" volume="337" first="425" last="425">
<title>New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred.</title>
<authorList>
<person name="Goldfarb L.G."/>
<person name="Haltia M."/>
<person name="Brown P."/>
<person name="Nieto A."/>
<person name="Kovanen J."/>
<person name="McCombie W.R."/>
<person name="Trapp S."/>
<person name="Gajdusek D.C."/>
</authorList>
<dbReference type="PubMed" id="1671440"/>
<dbReference type="DOI" id="10.1016/0140-6736(91)91198-4"/>
</citation>
<scope>VARIANT CJD ASN-178</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1990" name="Lancet" volume="336" first="514" last="515">
<title>Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia.</title>
<authorList>
<person name="Goldfarb L."/>
<person name="Mitrova E."/>
<person name="Brown P."/>
<person name="Toh B.K."/>
<person name="Gajdusek D.C."/>
</authorList>
<dbReference type="PubMed" id="1975028"/>
<dbReference type="DOI" id="10.1016/0140-6736(90)92073-Q"/>
</citation>
<scope>VARIANT CJD LYS-200</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1992" name="Nat. Genet." volume="1" first="68" last="71">
<title>Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles.</title>
<authorList>
<person name="Hsiao K."/>
<person name="Dlouhy S.R."/>
<person name="Farlow M.R."/>
<person name="Cass C."/>
<person name="da Costa M."/>
<person name="Conneally P.M."/>
<person name="Hodes M.E."/>
<person name="Ghetti B."/>
<person name="Prusiner S.B."/>
</authorList>
<dbReference type="PubMed" id="1363810"/>
<dbReference type="DOI" id="10.1038/ng0492-68"/>
</citation>
<scope>VARIANT GSD ARG-217</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1992" name="Science" volume="258" first="806" last="808">
<title>Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.</title>
<authorList>
<person name="Goldfarb L.G."/>
<person name="Petersen R.B."/>
<person name="Tabaton M."/>
<person name="Brown P."/>
<person name="LeBlanc A.C."/>
<person name="Montagna P."/>
<person name="Cortelli P."/>
<person name="Julien J."/>
<person name="Vital C."/>
<person name="Pendelbury W.W."/>
</authorList>
<dbReference type="PubMed" id="1439789"/>
<dbReference type="DOI" id="10.1126/science.1439789"/>
</citation>
<scope>VARIANT VAL-129</scope>
<scope>VARIANT CJD ASN-178</scope>
<scope>VARIANT FFI ASN-178</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-129</scope>
<scope>CHARACTERIZATION OF VARIANT CJD ASN-178</scope>
<scope>CHARACTERIZATION OF VARIANT FFI ASN-178</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="191" first="709" last="714">
<title>Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Straussler syndrome.</title>
<authorList>
<person name="Kitamoto T."/>
<person name="Ohta M."/>
<person name="Doh-Ura K."/>
<person name="Hitoshi S."/>
<person name="Terao Y."/>
<person name="Tateishi J."/>
</authorList>
<dbReference type="PubMed" id="8461023"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1275"/>
</citation>
<scope>VARIANTS CJD ILE-180 AND ARG-232</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1993" name="Ann. Neurol." volume="34" first="802" last="807">
<title>A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease.</title>
<authorList>
<person name="Pocchiari M."/>
<person name="Salvatore M."/>
<person name="Cutruzzola F."/>
<person name="Genuardi M."/>
<person name="Allcatelli C.T."/>
<person name="Masullo C."/>
<person name="Macchi G."/>
<person name="Alema G."/>
<person name="Galgani S."/>
<person name="Xi Y.G."/>
<person name="Petraroli R."/>
<person name="Silvestrini M.C."/>
<person name="Brunori M."/>
</authorList>
<dbReference type="PubMed" id="7902693"/>
<dbReference type="DOI" id="10.1002/ana.410340608"/>
</citation>
<scope>VARIANT CJD ILE-210</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1993" name="Neurology" volume="43" first="2723" last="2724">
<title>A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Straussler-Scheinker disease.</title>
<authorList>
<person name="Yamada M."/>
<person name="Itoh Y."/>
<person name="Fujigasaki H."/>
<person name="Naruse S."/>
<person name="Kaneko K."/>
<person name="Kitamoto T."/>
<person name="Tateishi J."/>
<person name="Otomo E."/>
<person name="Hayakawa M."/>
<person name="Tanaka J."/>
<person name="Matsushita M."/>
<person name="Miyatake T."/>
</authorList>
<dbReference type="PubMed" id="7902972"/>
<dbReference type="DOI" id="10.1212/WNL.43.12.2723-a"/>
</citation>
<scope>VARIANT GSD LEU-105</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1994" name="J. Neurol. Sci." volume="127" first="77" last="86">
<title>A variant of Gerstmann-Straussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study.</title>
<authorList>
<person name="Itoh Y."/>
<person name="Yamada M."/>
<person name="Hayakawa M."/>
<person name="Shozawa T."/>
<person name="Tanaka J."/>
<person name="Matsushita M."/>
<person name="Kitamoto T."/>
<person name="Tateishi J."/>
<person name="Otomo E."/>
</authorList>
<dbReference type="PubMed" id="7699395"/>
<dbReference type="DOI" id="10.1016/0022-510X(94)90138-4"/>
</citation>
<scope>VARIANT GSD LEU-105</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1994" name="Neurology" volume="44" first="299" last="301">
<title>Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene.</title>
<authorList>
<person name="Inoue I."/>
<person name="Kitamoto T."/>
<person name="Doh-Ura K."/>
<person name="Shii H."/>
<person name="Goto I."/>
<person name="Tateishi J."/>
</authorList>
<dbReference type="PubMed" id="7906019"/>
<dbReference type="DOI" id="10.1212/WNL.44.2.299"/>
</citation>
<scope>VARIANT CJD LYS-200</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1994" name="Philos. Trans. R. Soc. Lond., B, Biol. Sci." volume="343" first="385" last="390">
<title>Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.</title>
<authorList>
<person name="Gabizon R."/>
<person name="Rosenman H."/>
<person name="Meiner Z."/>
<person name="Kahana I."/>
<person name="Kahana E."/>
<person name="Shugart Y."/>
<person name="Ott J."/>
<person name="Prusiner S.B."/>
</authorList>
<dbReference type="PubMed" id="7913755"/>
<dbReference type="DOI" id="10.1098/rstb.1994.0033"/>
</citation>
<scope>VARIANT CJD LYS-200</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1995" name="Neurology" volume="45" first="1127" last="1134">
<title>Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients.</title>
<authorList>
<person name="Young K."/>
<person name="Jones C.K."/>
<person name="Piccardo P."/>
<person name="Lazzarini A."/>
<person name="Golbe L.I."/>
<person name="Zimmerman T.R."/>
<person name="Dickson D.W."/>
<person name="McLachlan D.C."/>
<person name="St George-Hyslop P.H."/>
<person name="Lennox A."/>
</authorList>
<dbReference type="PubMed" id="7783876"/>
<dbReference type="DOI" id="10.1212/WNL.45.6.1127"/>
</citation>
<scope>VARIANT GSD LEU-102</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1996" name="Neurology" volume="47" first="734" last="741">
<title>Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation).</title>
<authorList>
<person name="Barbanti P."/>
<person name="Fabbrini G."/>
<person name="Salvatore M."/>
<person name="Petraroli R."/>
<person name="Cardone F."/>
<person name="Maras B."/>
<person name="Equestre M."/>
<person name="Macchi G."/>
<person name="Lenzi G.L."/>
<person name="Pocchiari M."/>
</authorList>
<dbReference type="PubMed" id="8797472"/>
<dbReference type="DOI" id="10.1212/WNL.47.3.734"/>
</citation>
<scope>VARIANT GSD LEU-102</scope>
<scope>VARIANT LYS-219</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1996" name="Neurology" volume="47" first="1305" last="1312">
<title>Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease.</title>
<authorList>
<person name="Mastrianni J.A."/>
<person name="Iannicola C."/>
<person name="Myers R.M."/>
<person name="Dearmond S."/>
<person name="Prusiner S.B."/>
</authorList>
<dbReference type="PubMed" id="8909447"/>
<dbReference type="DOI" id="10.1212/WNL.47.5.1305"/>
</citation>
<scope>VARIANT CJD HIS-208</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1997" name="Ann. Neurol." volume="42" first="138" last="146">
<title>Familial spongiform encephalopathy associated with a novel prion protein gene mutation.</title>
<authorList>
<person name="Nitrini R."/>
<person name="Rosemberg S."/>
<person name="Passos-Bueno M.R."/>
<person name="da Silva L.S."/>
<person name="Iughetti P."/>
<person name="Papadopoulos M."/>
<person name="Carrilho P.M."/>
<person name="Caramelli P."/>
<person name="Albrecht S."/>
<person name="Zatz M."/>
<person name="Leblanc A."/>
</authorList>
<dbReference type="PubMed" id="9266722"/>
<dbReference type="DOI" id="10.1002/ana.410420203"/>
</citation>
<scope>VARIANT SENF ALA-183</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="J. Neuropathol. Exp. Neurol." volume="57" first="979" last="988">
<title>Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity.</title>
<authorList>
<person name="Piccardo P."/>
<person name="Dlouhy S.R."/>
<person name="Lievens P.M."/>
<person name="Young K."/>
<person name="Bird T.D."/>
<person name="Nochlin D."/>
<person name="Dickson D.W."/>
<person name="Vinters H.V."/>
<person name="Zimmerman T.R."/>
<person name="Mackenzie I.R."/>
<person name="Kish S.J."/>
<person name="Ang L.C."/>
<person name="De Carli C."/>
<person name="Pocchiari M."/>
<person name="Brown P."/>
<person name="Gibbs C.J. Jr."/>
<person name="Gajdusek D.C."/>
<person name="Bugiani O."/>
<person name="Ironside J."/>
<person name="Tagliavini F."/>
<person name="Ghetti B."/>
</authorList>
<dbReference type="PubMed" id="9786248"/>
<dbReference type="DOI" id="10.1097/00005072-199810000-00010"/>
</citation>
<scope>VARIANTS GSD ASN-202 AND PRO-212</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1998" name="Lancet" volume="351" first="419" last="419">
<title>Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease.</title>
<authorList>
<person name="Shibuya S."/>
<person name="Higuchi J."/>
<person name="Shin R.W."/>
<person name="Tateishi J."/>
<person name="Kitamoto T."/>
</authorList>
<dbReference type="PubMed" id="9482303"/>
<dbReference type="DOI" id="10.1016/S0140-6736(05)78358-6"/>
</citation>
<scope>VARIANT LYS-219</scope>
<scope>CHARACTERIZATION OF VARIANT LYS-219</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1999" name="Hum. Genet." volume="105" first="244" last="252">
<title>Molecular genetics of human prion diseases in Germany.</title>
<authorList>
<person name="Windl O."/>
<person name="Giese A."/>
<person name="Schulz-Schaeffer W."/>
<person name="Zerr I."/>
<person name="Skworc K."/>
<person name="Arendt S."/>
<person name="Oberdieck C."/>
<person name="Bodemer M."/>
<person name="Poser S."/>
<person name="Kretzschmar H.A."/>
</authorList>
<dbReference type="PubMed" id="10987652"/>
<dbReference type="DOI" id="10.1007/s004390051096"/>
</citation>
<scope>VARIANTS ARG-188 AND SER-238</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="110" last="117">
<title>High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.</title>
<authorList>
<person name="Finckh U."/>
<person name="Mueller-Thomsen T."/>
<person name="Mann U."/>
<person name="Eggers C."/>
<person name="Marksteiner J."/>
<person name="Meins W."/>
<person name="Binetti G."/>
<person name="Alberici A."/>
<person name="Hock C."/>
<person name="Nitsch R.M."/>
<person name="Gal A."/>
</authorList>
<dbReference type="PubMed" id="10631141"/>
<dbReference type="DOI" id="10.1086/302702"/>
</citation>
<scope>VARIANTS EARLY-ONSET DEMENTIA LEU-102; ALA-183 AND LYS-188</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2000" name="Hum. Mutat." volume="15" first="482" last="482">
<title>Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.</title>
<authorList>
<person name="Peoc'h K."/>
<person name="Manivet P."/>
<person name="Beaudry P."/>
<person name="Attane F."/>
<person name="Besson G."/>
<person name="Didier H."/>
<person name="Delasnerie-Laupretre N."/>
<person name="Laplanche J.-L."/>
</authorList>
<dbReference type="PubMed" id="10790216"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(200005)15:5&lt;482::AID-HUMU16>3.0.CO;2-1"/>
</citation>
<scope>VARIANTS CJD LYS-196; ILE-203 AND GLN-211</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2001" name="Arch. Neurol." volume="58" first="1899" last="1902">
<title>A new PRNP mutation (G131V) associated with Gerstmann-Straussler-Scheinker disease.</title>
<authorList>
<person name="Panegyres P.K."/>
<person name="Toufexis K."/>
<person name="Kakulas B.A."/>
<person name="Cernevakova L."/>
<person name="Brown P."/>
<person name="Ghetti B."/>
<person name="Piccardo P."/>
<person name="Dlouhy S.R."/>
</authorList>
<dbReference type="PubMed" id="11709001"/>
<dbReference type="DOI" id="10.1001/archneur.58.11.1899"/>
</citation>
<scope>VARIANT GSD VAL-131</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2003" name="Science" volume="300" first="640" last="643">
<title>Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.</title>
<authorList>
<person name="Mead S."/>
<person name="Stumpf M.P."/>
<person name="Whitfield J."/>
<person name="Beck J.A."/>
<person name="Poulter M."/>
<person name="Campbell T."/>
<person name="Uphill J.B."/>
<person name="Goldstein D."/>
<person name="Alpers M."/>
<person name="Fisher E.M."/>
<person name="Collinge J."/>
</authorList>
<dbReference type="PubMed" id="12690204"/>
<dbReference type="DOI" id="10.1126/science.1083320"/>
</citation>
<scope>VARIANT VAL-129</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-129</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="N. Engl. J. Med." volume="361" first="2056" last="2065">
<title>A novel protective prion protein variant that colocalizes with kuru exposure.</title>
<authorList>
<person name="Mead S."/>
<person name="Whitfield J."/>
<person name="Poulter M."/>
<person name="Shah P."/>
<person name="Uphill J."/>
<person name="Campbell T."/>
<person name="Al-Dujaily H."/>
<person name="Hummerich H."/>
<person name="Beck J."/>
<person name="Mein C.A."/>
<person name="Verzilli C."/>
<person name="Whittaker J."/>
<person name="Alpers M.P."/>
<person name="Collinge J."/>
</authorList>
<dbReference type="PubMed" id="19923577"/>
<dbReference type="DOI" id="10.1056/NEJMoa0809716"/>
</citation>
<scope>VARIANT VAL-127</scope>
<scope>INVOLVEMENT IN KURU</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2015" name="Nature" volume="522" first="478" last="481">
<title>A naturally occurring variant of the human prion protein completely prevents prion disease.</title>
<authorList>
<person name="Asante E.A."/>
<person name="Smidak M."/>
<person name="Grimshaw A."/>
<person name="Houghton R."/>
<person name="Tomlinson A."/>
<person name="Jeelani A."/>
<person name="Jakubcova T."/>
<person name="Hamdan S."/>
<person name="Richard-Londt A."/>
<person name="Linehan J.M."/>
<person name="Brandner S."/>
<person name="Alpers M."/>
<person name="Whitfield J."/>
<person name="Mead S."/>
<person name="Wadsworth J.D."/>
<person name="Collinge J."/>
</authorList>
<dbReference type="PubMed" id="26061765"/>
<dbReference type="DOI" id="10.1038/nature14510"/>
</citation>
<scope>VARIANT VAL-127</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-127</scope>
<scope>INVOLVEMENT IN KURU</scope>
<scope>POLYMORPHISM</scope>
</reference>
<comment type="function">
<text evidence="15 25 41 43 64">Its primary physiological function is unclear. Has cytoprotective activity against internal or environmental stresses. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (PubMed:12732622, PubMed:19936054, PubMed:20564047). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="15 20 22 30 34 36 40 42 43 44">Monomer and homodimer. Has a tendency to aggregate into amyloid fibrils containing a cross-beta spine, formed by a steric zipper of superposed beta-strands. Soluble oligomers may represent an intermediate stage on the path to fibril formation. Copper binding may promote oligomerization (PubMed:11524679, PubMed:11900542, PubMed:14623188, PubMed:17468747, PubMed:19204296, PubMed:19927125, PubMed:20375014, PubMed:20564047). Interacts with GRB2, APP, ERI3/PRNPIP and SYN1. Mislocalized cytosolically exposed PrP interacts with MGRN1; this interaction alters MGRN1 subcellular location and causes lysosomal enlargement (By similarity). Interacts with KIAA1191 (PubMed:21153684).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-977302"/>
<organismsDiffer>false</organismsDiffer>
<experiments>17</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-77613">
<id>P05067</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-302641">
<id>P05067-4</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-2568609">
<id>Q9BSJ6</id>
<label>FAM64A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8830282"/>
<interactant intactId="EBI-8830305">
<id>P31424-2</id>
<label>Grm5</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-740785">
<id>P49639</id>
<label>HOXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-366182">
<id>P10636</id>
<label>MAPT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-1043398">
<id>P29372</id>
<label>MPG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8830282"/>
<interactant intactId="EBI-647785">
<id>P52480</id>
<label>Pkm</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-751877">
<id>Q9H4B4</id>
<label>PLK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-7430632">
<id>P10279</id>
<label>PRNP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-7670302">
<id>P23907</id>
<label>PRNP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-977302"/>
<interactant intactId="EBI-768613">
<id>P04925</id>
<label>Prnp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology evidence="41">Lipid-anchor</topology>
<topology evidence="41">GPI-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Golgi apparatus</location>
</subcellularLocation>
<text evidence="41">Targeted to lipid rafts via association with the heparan sulfate chains of GPC1. Colocates, in the presence of Cu(2+), to vesicles in para- and perinuclear regions, where both proteins undergo internalization. Heparin displaces PRNP from lipid rafts and promotes endocytosis.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="35">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Nucleus</location>
</subcellularLocation>
<text evidence="35">Accumulates outside the secretory route in the cytoplasm, from where it relocates to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative initiation"/>
<isoform>
<id>P04156-1</id>
<name>1</name>
<name>PrP</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04156-2</id>
<name>2</name>
<name>PrP(M8)</name>
<sequence type="described" ref="VSP_039045"/>
</isoform>
<isoform>
<id>F7VJQ1-1</id>
<name>3</name>
<name>AltPrP</name>
<sequence type="external"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="34 40 43">The normal, monomeric form, PRPN(C), has a mainly alpha-helical structure. Misfolding of this form produces a disease-associated, protease-resistant form, PRPN (Sc), accompanied by a large increase of the beta-sheet content and formation of amyloid fibrils. These fibrils consist of a cross-beta spine, formed by a steric zipper of superposed beta-strands. Disease mutations may favor intermolecular contacts via short beta strands, and may thereby trigger oligomerization. In addition, the heparan-sulfate proteoglycan, GPC1, promotes the association of PRPN (C) to lipid rafts and appears to facilitate the conversion to PRPN (Sc).</text>
</comment>
<comment type="domain">
<text evidence="20 22 42">Contains an N-terminal region composed of octamer repeats. At low copper concentrations, the sidechains of His residues from three or four repeats contribute to the binding of a single copper ion. Alternatively, a copper ion can be bound by interaction with the sidechain and backbone amide nitrogen of a single His residue. The observed copper binding stoichiometry suggests that two repeat regions cooperate to stabilize the binding of a single copper ion. At higher copper concentrations, each octamer can bind one copper ion by interactions with the His sidechain and Gly backbone atoms. A mixture of binding types may occur, especially in the case of octamer repeat expansion. Copper binding may stabilize the conformation of this region and may promote oligomerization.</text>
</comment>
<comment type="PTM">
<text evidence="23">The glycosylation pattern (the amount of mono-, di- and non-glycosylated forms or glycoforms) seems to differ in normal and CJD prion.</text>
</comment>
<comment type="PTM">
<text evidence="14">Isoform 2 is sumoylated with SUMO1.</text>
</comment>
<comment type="polymorphism">
<text evidence="33">The five tandem octapeptide repeats region is highly unstable. Insertions or deletions of octapeptide repeat units are associated to prion disease.</text>
</comment>
<comment type="polymorphism">
<text evidence="29 46 61">A number of polymorphisms confer resistance to prion diseases (PubMed:1439789, PubMed:9482303, PubMed:19923577, PubMed:26061765). Val-127 has been selected for in response to the Kuru epidemic and confers resistance to prion disease by acting as a 'dominant negative' inhibitor of prion conversion (PubMed:26061765). Val-127 is not only itself resistant to conformational conversion, but also inhibits conversion of wild-type proteins. Confers protection against classical Creutzfeldt-Jakob disease (CJD) and Kuru in the heterozygous state, but can be infected with variant CJD prions, resulting from exposure to bovine spongiform encephalopathy prions. Confers complete resistance to all prion strains when homozygous (PubMed:26061765). Always associated with M-129 variant (PubMed:26061765). Val-129 confers relative protection against acquired, sporadic and some inherited prion diseases in the heterozygous state, possibly by preventing homodimerization (PubMed:1439789). Lys-219 confers relative protection against sporadic Creutzfeldt-Jakob disease (CJD) in the heterozygous state (PubMed:9482303).</text>
</comment>
<comment type="disease">
<text evidence="55">PrP is found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases, like: Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), Gerstmann-Straussler disease (GSD), Huntington disease-like type 1 (HDL1) and kuru in humans; scrapie in sheep and goat; bovine spongiform encephalopathy (BSE) in cattle; transmissible mink encephalopathy (TME); chronic wasting disease (CWD) of mule deer and elk; feline spongiform encephalopathy (FSE) in cats and exotic ungulate encephalopathy (EUE) in nyala and greater kudu. The prion diseases illustrate three manifestations of CNS degeneration: (1) infectious (2) sporadic and (3) dominantly inherited forms. TME, CWD, BSE, FSE, EUE are all thought to occur after consumption of prion-infected foodstuffs.</text>
</comment>
<comment type="disease" evidence="18 29 31 38 40 51 53 54 56 58">
<disease id="DI-01448">
<name>Creutzfeldt-Jakob disease</name>
<acronym>CJD</acronym>
<description>Occurs primarily as a sporadic disorder (1 per million), while 10-15% are familial. Accidental transmission of CJD to humans appears to be iatrogenic (contaminated human growth hormone (HGH), corneal transplantation, electroencephalographic electrode implantation, etc.). Epidemiologic studies have failed to implicate the ingestion of infected animal meat in the pathogenesis of CJD in human. The triad of microscopic features that characterize the prion diseases consists of (1) spongiform degeneration of neurons, (2) severe astrocytic gliosis that often appears to be out of proportion to the degree of nerve cell loss, and (3) amyloid plaque formation. CJD is characterized by progressive dementia and myoclonic seizures, affecting adults in mid-life. Some patients present sleep disorders, abnormalities of high cortical function, cerebellar and corticospinal disturbances. The disease ends in death after a 3-12 months illness.</description>
<dbReference type="MIM" id="123400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="26 29 40">
<disease id="DI-01607">
<name>Fatal familial insomnia</name>
<acronym>FFI</acronym>
<description>Autosomal dominant disorder and is characterized by neuronal degeneration limited to selected thalamic nuclei and progressive insomnia.</description>
<dbReference type="MIM" id="600072"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="16 21 28 29 40 45 49 50 52 57 62">
<disease id="DI-01656">
<name>Gerstmann-Straussler disease</name>
<acronym>GSD</acronym>
<description>A rare inherited prion disease characterized by adult onset of memory loss, dementia, ataxia, and pathologic deposition of amyloid-like plaques in the brain. GSD presents with progressive limb and truncal ataxia, dysarthria, and cognitive decline in the thirties and forties, and the average disease duration is 7 years.</description>
<dbReference type="MIM" id="137440"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01755">
<name>Huntington disease-like 1</name>
<acronym>HDL1</acronym>
<description>Autosomal dominant, early-onset neurodegenerative disorder with prominent psychiatric features.</description>
<dbReference type="MIM" id="603218"/>
</disease>
<text evidence="63">The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="39 46">
<disease id="DI-01871">
<name>Kuru</name>
<acronym>KURU</acronym>
<description>Kuru is transmitted during ritualistic cannibalism, among natives of the New Guinea highlands. Patients exhibit various movement disorders like cerebellar abnormalities, rigidity of the limbs, and clonus. Emotional lability is present, and dementia is conspicuously absent. Death usually occurs from 3 to 12 month after onset.</description>
<dbReference type="MIM" id="245300"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="59">
<disease id="DI-02210">
<name>Spongiform encephalopathy with neuropsychiatric features</name>
<acronym>SENF</acronym>
<description>Autosomal dominant presenile dementia with a rapidly progressive and protracted clinical course. The dementia was characterized clinically by frontotemporal features, including early personality changes. Some patients had memory loss, several showed aggressiveness, hyperorality and verbal stereotypy, others had parkinsonian symptoms.</description>
<dbReference type="MIM" id="606688"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="66">This protein is produced by a bicistronic gene which also produces the The alternative prion protein/AltPrP (AC F7VJQ1) from an overlapping reading frame.</text>
</comment>
<comment type="miscellaneous">
<text evidence="64">The alternative prion protein/AltPrP (AC F7VJQ1) and PRNP have no apparent direct functional relation since a mutation that removes the start codon of the AltPrP has no apparent effect on the biology of PRNP. In mouse and hamster, the alternative initiation AUG codon is absent and is replaced by a GUG codon.</text>
</comment>
<comment type="similarity">
<text evidence="64">Belongs to the prion family.</text>
</comment>
<comment type="online information" name="The Official Mad Cow Disease Home Page">
<link uri="http://www.mad-cow.org/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/PRNP"/>
<text>PRNP entry</text>
</comment>
<dbReference type="EMBL" id="M13899">
<property type="protein sequence ID" value="AAA60182.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X83416">
<property type="protein sequence ID" value="CAA58442.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U29185">
<property type="protein sequence ID" value="AAC78725.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF076976">
<property type="protein sequence ID" value="AAD46098.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY008282">
<property type="protein sequence ID" value="AAG21693.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ408531">
<property type="protein sequence ID" value="ABD63004.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133396">
<property type="protein sequence ID" value="CAB75503.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL133396">
<property type="protein sequence ID" value="CAI19053.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012844">
<property type="protein sequence ID" value="AAH12844.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC022532">
<property type="protein sequence ID" value="AAH22532.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D00015">
<property type="protein sequence ID" value="BAA00011.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M13667">
<property type="protein sequence ID" value="AAA19664.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M81929">
<property type="protein sequence ID" value="AAB59442.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M81930">
<property type="protein sequence ID" value="AAB59443.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF030575">
<property type="protein sequence ID" value="AAC05365.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S80732">
<property type="protein sequence ID" value="AAB50648.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S80743">
<property type="protein sequence ID" value="AAB50649.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S71208">
<property type="protein sequence ID" value="AAB20521.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S71210">
<property type="protein sequence ID" value="AAB20522.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S71212">
<property type="protein sequence ID" value="AAB20523.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13080.1">
<molecule id="P04156-1"/>
</dbReference>
<dbReference type="PIR" id="A24173">
<property type="entry name" value="UJHU"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000302.1">
<molecule id="P04156-1"/>
<property type="nucleotide sequence ID" value="NM_000311.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073590.1">
<molecule id="P04156-1"/>
<property type="nucleotide sequence ID" value="NM_001080121.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073591.1">
<molecule id="P04156-1"/>
<property type="nucleotide sequence ID" value="NM_001080122.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001073592.1">
<molecule id="P04156-1"/>
<property type="nucleotide sequence ID" value="NM_001080123.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_898902.1">
<molecule id="P04156-1"/>
<property type="nucleotide sequence ID" value="NM_183079.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.472010"/>
<dbReference type="UniGene" id="Hs.610285"/>
<dbReference type="UniGene" id="Hs.721670"/>
<dbReference type="PDB" id="1E1G">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1E1J">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1E1P">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1E1S">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1E1U">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1E1W">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1FKC">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="1FO7">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="1H0L">
<property type="method" value="NMR"/>
<property type="chains" value="A=121-230"/>
</dbReference>
<dbReference type="PDB" id="1HJM">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1HJN">
<property type="method" value="NMR"/>
<property type="chains" value="A=125-228"/>
</dbReference>
<dbReference type="PDB" id="1I4M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=119-226"/>
</dbReference>
<dbReference type="PDB" id="1OEH">
<property type="method" value="NMR"/>
<property type="chains" value="A=77-84"/>
</dbReference>
<dbReference type="PDB" id="1OEI">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-84"/>
</dbReference>
<dbReference type="PDB" id="1QLX">
<property type="method" value="NMR"/>
<property type="chains" value="A=23-230"/>
</dbReference>
<dbReference type="PDB" id="1QLZ">
<property type="method" value="NMR"/>
<property type="chains" value="A=23-230"/>
</dbReference>
<dbReference type="PDB" id="1QM0">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-230"/>
</dbReference>
<dbReference type="PDB" id="1QM1">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-230"/>
</dbReference>
<dbReference type="PDB" id="1QM2">
<property type="method" value="NMR"/>
<property type="chains" value="A=121-230"/>
</dbReference>
<dbReference type="PDB" id="1QM3">
<property type="method" value="NMR"/>
<property type="chains" value="A=121-230"/>
</dbReference>
<dbReference type="PDB" id="2IV4">
<property type="method" value="NMR"/>
<property type="chains" value="A=180-195"/>
</dbReference>
<dbReference type="PDB" id="2IV5">
<property type="method" value="NMR"/>
<property type="chains" value="A=173-195"/>
</dbReference>
<dbReference type="PDB" id="2IV6">
<property type="method" value="NMR"/>
<property type="chains" value="A=173-195"/>
</dbReference>
<dbReference type="PDB" id="2K1D">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2KUN">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2LBG">
<property type="method" value="NMR"/>
<property type="chains" value="A=110-136"/>
</dbReference>
<dbReference type="PDB" id="2LEJ">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2LFT">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2LSB">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2LV1">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2M8T">
<property type="method" value="NMR"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="2OL9">
<property type="method" value="X-ray"/>
<property type="resolution" value="0.85"/>
<property type="chains" value="A=170-175"/>
</dbReference>
<dbReference type="PDB" id="2W9E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=119-231"/>
</dbReference>
<dbReference type="PDB" id="3HAF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDB" id="3HAK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=125-227"/>
</dbReference>
<dbReference type="PDB" id="3HEQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=90-231"/>
</dbReference>
<dbReference type="PDB" id="3HER">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=90-231"/>
</dbReference>
<dbReference type="PDB" id="3HES">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=90-231"/>
</dbReference>
<dbReference type="PDB" id="3HJ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=90-231"/>
</dbReference>
<dbReference type="PDB" id="3HJX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=126-231"/>
</dbReference>
<dbReference type="PDB" id="3MD4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.15"/>
<property type="chains" value="A/B=127-132"/>
</dbReference>
<dbReference type="PDB" id="3MD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B=127-132"/>
</dbReference>
<dbReference type="PDB" id="3NHC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.57"/>
<property type="chains" value="A/B=127-132"/>
</dbReference>
<dbReference type="PDB" id="3NHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.92"/>
<property type="chains" value="A/B=127-132"/>
</dbReference>
<dbReference type="PDB" id="3NVF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=138-143"/>
</dbReference>
<dbReference type="PDB" id="4DGI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=120-230"/>
</dbReference>
<dbReference type="PDB" id="4E1H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/C/E/G/I/K=177-182, B/D/F/H/J/L=211-216"/>
</dbReference>
<dbReference type="PDB" id="4E1I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A/C/E/G/I/K=177-182, B/D/F/H/J/L=211-216"/>
</dbReference>
<dbReference type="PDB" id="4KML">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=24-231"/>
</dbReference>
<dbReference type="PDB" id="4N9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=90-231"/>
</dbReference>
<dbReference type="PDBsum" id="1E1G"/>
<dbReference type="PDBsum" id="1E1J"/>
<dbReference type="PDBsum" id="1E1P"/>
<dbReference type="PDBsum" id="1E1S"/>
<dbReference type="PDBsum" id="1E1U"/>
<dbReference type="PDBsum" id="1E1W"/>
<dbReference type="PDBsum" id="1FKC"/>
<dbReference type="PDBsum" id="1FO7"/>
<dbReference type="PDBsum" id="1H0L"/>
<dbReference type="PDBsum" id="1HJM"/>
<dbReference type="PDBsum" id="1HJN"/>
<dbReference type="PDBsum" id="1I4M"/>
<dbReference type="PDBsum" id="1OEH"/>
<dbReference type="PDBsum" id="1OEI"/>
<dbReference type="PDBsum" id="1QLX"/>
<dbReference type="PDBsum" id="1QLZ"/>
<dbReference type="PDBsum" id="1QM0"/>
<dbReference type="PDBsum" id="1QM1"/>
<dbReference type="PDBsum" id="1QM2"/>
<dbReference type="PDBsum" id="1QM3"/>
<dbReference type="PDBsum" id="2IV4"/>
<dbReference type="PDBsum" id="2IV5"/>
<dbReference type="PDBsum" id="2IV6"/>
<dbReference type="PDBsum" id="2K1D"/>
<dbReference type="PDBsum" id="2KUN"/>
<dbReference type="PDBsum" id="2LBG"/>
<dbReference type="PDBsum" id="2LEJ"/>
<dbReference type="PDBsum" id="2LFT"/>
<dbReference type="PDBsum" id="2LSB"/>
<dbReference type="PDBsum" id="2LV1"/>
<dbReference type="PDBsum" id="2M8T"/>
<dbReference type="PDBsum" id="2OL9"/>
<dbReference type="PDBsum" id="2W9E"/>
<dbReference type="PDBsum" id="3HAF"/>
<dbReference type="PDBsum" id="3HAK"/>
<dbReference type="PDBsum" id="3HEQ"/>
<dbReference type="PDBsum" id="3HER"/>
<dbReference type="PDBsum" id="3HES"/>
<dbReference type="PDBsum" id="3HJ5"/>
<dbReference type="PDBsum" id="3HJX"/>
<dbReference type="PDBsum" id="3MD4"/>
<dbReference type="PDBsum" id="3MD5"/>
<dbReference type="PDBsum" id="3NHC"/>
<dbReference type="PDBsum" id="3NHD"/>
<dbReference type="PDBsum" id="3NVF"/>
<dbReference type="PDBsum" id="4DGI"/>
<dbReference type="PDBsum" id="4E1H"/>
<dbReference type="PDBsum" id="4E1I"/>
<dbReference type="PDBsum" id="4KML"/>
<dbReference type="PDBsum" id="4N9O"/>
<dbReference type="DisProt" id="DP00466"/>
<dbReference type="ProteinModelPortal" id="P04156"/>
<dbReference type="SMR" id="P04156">
<property type="residue range" value="2-28, 90-231"/>
</dbReference>
<dbReference type="BioGrid" id="111606">
<property type="interactions" value="58"/>
</dbReference>
<dbReference type="DIP" id="DIP-29933N"/>
<dbReference type="IntAct" id="P04156">
<property type="interactions" value="88"/>
</dbReference>
<dbReference type="MINT" id="MINT-1420984"/>
<dbReference type="STRING" id="9606.ENSP00000368752"/>
<dbReference type="BindingDB" id="P04156"/>
<dbReference type="ChEMBL" id="CHEMBL4869"/>
<dbReference type="DrugBank" id="DB00759">
<property type="generic name" value="Tetracycline"/>
</dbReference>
<dbReference type="iPTMnet" id="P04156"/>
<dbReference type="PhosphoSite" id="P04156"/>
<dbReference type="BioMuta" id="PRNP"/>
<dbReference type="DMDM" id="130912"/>
<dbReference type="EPD" id="P04156"/>
<dbReference type="PaxDb" id="P04156"/>
<dbReference type="PRIDE" id="P04156"/>
<dbReference type="DNASU" id="5621"/>
<dbReference type="Ensembl" id="ENST00000379440">
<molecule id="P04156-1"/>
<property type="protein sequence ID" value="ENSP00000368752"/>
<property type="gene ID" value="ENSG00000171867"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000430350">
<molecule id="P04156-1"/>
<property type="protein sequence ID" value="ENSP00000399376"/>
<property type="gene ID" value="ENSG00000171867"/>
</dbReference>
<dbReference type="GeneID" id="5621"/>
<dbReference type="KEGG" id="hsa:5621"/>
<dbReference type="CTD" id="5621"/>
<dbReference type="GeneCards" id="PRNP"/>
<dbReference type="GeneReviews" id="PRNP"/>
<dbReference type="HGNC" id="HGNC:9449">
<property type="gene designation" value="PRNP"/>
</dbReference>
<dbReference type="HPA" id="HPA042754"/>
<dbReference type="HPA" id="HPA043398"/>
<dbReference type="MalaCards" id="PRNP"/>
<dbReference type="MIM" id="123400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="137440">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176640">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="245300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600072">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603218">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606688">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04156"/>
<dbReference type="Orphanet" id="397606">
<property type="disease" value="Chronic diarrhea with hereditary sensory and autonomic neuropathy"/>
</dbReference>
<dbReference type="Orphanet" id="280397">
<property type="disease" value="Familial Alzheimer-like prion disease"/>
</dbReference>
<dbReference type="Orphanet" id="466">
<property type="disease" value="Fatal familial insomnia"/>
</dbReference>
<dbReference type="Orphanet" id="356">
<property type="disease" value="Gerstmann-Straussler-Scheinker syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="157941">
<property type="disease" value="Huntington disease-like 1"/>
</dbReference>
<dbReference type="Orphanet" id="282166">
<property type="disease" value="Inherited Creutzfeldt-Jakob disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33796"/>
<dbReference type="eggNOG" id="ENOG410IJMM">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YXUU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOVERGEN" id="HBG008260"/>
<dbReference type="InParanoid" id="P04156"/>
<dbReference type="KO" id="K05634"/>
<dbReference type="OMA" id="HNPGYPH"/>
<dbReference type="OrthoDB" id="EOG7DRJ4Q"/>
<dbReference type="PhylomeDB" id="P04156"/>
<dbReference type="TreeFam" id="TF105188"/>
<dbReference type="Reactome" id="R-HSA-419037">
<property type="pathway name" value="NCAM1 interactions"/>
</dbReference>
<dbReference type="ChiTaRS" id="PRNP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04156"/>
<dbReference type="GenomeRNAi" id="5621"/>
<dbReference type="NextBio" id="21844"/>
<dbReference type="PMAP-CutDB" id="P04156"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="P04156"/>
<dbReference type="ExpressionAtlas" id="P04156">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04156">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031225">
<property type="term" value="C:anchored component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019898">
<property type="term" value="C:extrinsic component of membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005507">
<property type="term" value="F:copper ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006878">
<property type="term" value="P:cellular copper ion homeostasis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071280">
<property type="term" value="P:cellular response to copper ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008152">
<property type="term" value="P:metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046007">
<property type="term" value="P:negative regulation of activated T cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070885">
<property type="term" value="P:negative regulation of calcineurin-NFAT signaling cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032689">
<property type="term" value="P:negative regulation of interferon-gamma production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032700">
<property type="term" value="P:negative regulation of interleukin-17 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032703">
<property type="term" value="P:negative regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001933">
<property type="term" value="P:negative regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043433">
<property type="term" value="P:negative regulation of sequence-specific DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050860">
<property type="term" value="P:negative regulation of T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1901379">
<property type="term" value="P:regulation of potassium ion transmembrane transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032880">
<property type="term" value="P:regulation of protein localization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046686">
<property type="term" value="P:response to cadmium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.790.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000817">
<property type="entry name" value="Prion"/>
</dbReference>
<dbReference type="InterPro" id="IPR022416">
<property type="entry name" value="Prion/Doppel_prot_b-ribbon_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR025860">
<property type="entry name" value="Prion_N_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10502:SF11">
<property type="entry name" value="PTHR10502:SF11"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00377">
<property type="entry name" value="Prion"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11587">
<property type="entry name" value="Prion_bPrPp"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00341">
<property type="entry name" value="PRION"/>
</dbReference>
<dbReference type="SMART" id="SM00157">
<property type="entry name" value="PRP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54098">
<property type="entry name" value="SSF54098"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00291">
<property type="entry name" value="PRION_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00706">
<property type="entry name" value="PRION_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0034">Amyloid</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0186">Copper</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0336">GPI-anchor</keyword>
<keyword id="KW-0338">Growth arrest</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0640">Prion</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="signal peptide" evidence="15">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Major prion protein" id="PRO_0000025675">
<location>
<begin position="23"/>
<end position="230"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000025676" evidence="14">
<location>
<begin position="231"/>
<end position="253"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="51"/>
<end position="59"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="60"/>
<end position="67"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="68"/>
<end position="75"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="76"/>
<end position="83"/>
</location>
</feature>
<feature type="repeat" description="5">
<location>
<begin position="84"/>
<end position="91"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with GRB2, ERI3 and SYN1" evidence="15">
<location>
<begin position="23"/>
<end position="230"/>
</location>
</feature>
<feature type="region of interest" description="5 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q">
<location>
<begin position="51"/>
<end position="91"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 1" evidence="22">
<location>
<position position="61"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 1; via amide nitrogen" evidence="22">
<location>
<position position="62"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 1; via amide nitrogen and carbonyl oxygen" evidence="22">
<location>
<position position="63"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 2" evidence="65">
<location>
<position position="69"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 2; via amide nitrogen" evidence="65">
<location>
<position position="70"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 2; via amide nitrogen and carbonyl oxygen" evidence="65">
<location>
<position position="71"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 3" evidence="65">
<location>
<position position="77"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 3; via amide nitrogen" evidence="65">
<location>
<position position="78"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 3; via amide nitrogen and carbonyl oxygen" evidence="65">
<location>
<position position="79"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 4" evidence="65">
<location>
<position position="85"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 4; via amide nitrogen" evidence="65">
<location>
<position position="86"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Copper or zinc 4; via amide nitrogen and carbonyl oxygen" evidence="65">
<location>
<position position="87"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="GPI-anchor amidated serine" evidence="14">
<location>
<position position="230"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="23">
<location>
<position position="181"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...)" evidence="37">
<location>
<position position="197"/>
</location>
</feature>
<feature type="disulfide bond" evidence="30">
<location>
<begin position="179"/>
<end position="214"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_039045" evidence="64">
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_013763" evidence="27 32 48">
<location>
<begin position="56"/>
<end position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD and early-onset dementia." id="VAR_006464" evidence="17 45 47 50 57">
<original>P</original>
<variation>L</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD." id="VAR_006465" evidence="49 52">
<original>P</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="Linked to development of dementing Gerstmann-Straussler disease." id="VAR_006466" evidence="47">
<original>A</original>
<variation>V</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; variant that has been selected for in response to the Kuru epidemic and confers resistance to prion disease by acting as a 'dominant negative' inhibitor of prion conversion; is not only itself resistant to conformational conversion, but also inhibits conversion of wild-type proteins; confers protection against classical Creutzfeldt-Jakob disease (CJD) and Kuru in the heterozygous state, but can be infected with variant CJD prions, resulting from exposure to bovine spongiform encephalopathy prions; confers complete resistance to all prion strains when homozygous. Always associated with M-129 variant." id="VAR_073722" evidence="39 46">
<original>G</original>
<variation>V</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; confers relative protection against acquired, sporadic and some inherited prion diseases in the heterozygous state, possibly by preventing homodimerization; determines the disease phenotype in patients who have a PrP mutation at position 178; patients with M-129 develop FFI, those with V-129 develop CJD; dbSNP:rs1799990." id="VAR_006467" evidence="24 29 40 47">
<original>M</original>
<variation>V</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD." id="VAR_014264" evidence="21">
<original>G</original>
<variation>V</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In schizoaffective disorder; dbSNP:rs16990018." id="VAR_006468" evidence="60">
<original>N</original>
<variation>S</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In FFI and CJD." id="VAR_006469" evidence="26 29 31 40">
<original>D</original>
<variation>N</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_006470" evidence="29 40 56">
<original>V</original>
<variation>I</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In SENF and early-onset dementia; induces loss of glycosylation at N-181." id="VAR_006471" evidence="17 23 59">
<original>T</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD." id="VAR_008746" evidence="16">
<original>H</original>
<variation>R</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence variant" description="In early-onset dementia; dementia associated to prion diseases." id="VAR_008748" evidence="17">
<original>T</original>
<variation>K</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008747" evidence="19">
<original>T</original>
<variation>R</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_008749" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD; atypical form with neurofibrillary tangles." id="VAR_006472" evidence="40">
<original>F</original>
<variation>S</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_006473" evidence="38 53 54">
<original>E</original>
<variation>K</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD." id="VAR_008750" evidence="62">
<original>D</original>
<variation>N</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD; unknown pathological significance." id="VAR_008751" evidence="18">
<original>V</original>
<variation>I</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_006474" evidence="58">
<original>R</original>
<variation>H</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_006475" evidence="51">
<original>V</original>
<variation>I</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_008752" evidence="18">
<original>E</original>
<variation>Q</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD." id="VAR_008753" evidence="62">
<original>Q</original>
<variation>P</variation>
<location>
<position position="212"/>
</location>
</feature>
<feature type="sequence variant" description="In GSD; with neurofibrillary tangles." id="VAR_006476" evidence="28">
<original>Q</original>
<variation>R</variation>
<location>
<position position="217"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; confers relative protection against sporadic Creutzfeldt-Jakob disease (CJD) in the heterozygous state; dbSNP:rs1800014." id="VAR_006477" evidence="57 61">
<original>E</original>
<variation>K</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="sequence variant" description="In CJD." id="VAR_006478" evidence="56">
<original>M</original>
<variation>R</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_008754" evidence="19">
<original>P</original>
<variation>S</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="mutagenesis site" description="Protein detected. No protein detected; when associated with S-8." evidence="35">
<original>M</original>
<variation>S</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="mutagenesis site" description="No protein detected; when associated with S-1." evidence="35">
<original>M</original>
<variation>S</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAA19664/BAA00011." ref="9" evidence="64">
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; ABD63004." ref="6" evidence="64">
<original>Y</original>
<variation>H</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH22532." ref="8" evidence="64">
<original>Q</original>
<variation>K</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="118"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="125"/>
<end position="127"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="144"/>
<end position="153"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="159"/>
<end position="163"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="185"/>
<end position="187"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1E1P"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1E1S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1E1U"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1H0L"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OEH"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1OEI"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QM0"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LFT"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HAK"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HER"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MD4"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4E1H"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KML"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P04273"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P04925"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10581485"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10631141"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10790216"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10987652"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11524679"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11709001"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11900542"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12214108"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12690204"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12732622"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1347910"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1363802"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1363810"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1439789"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14623188"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1671440"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1678248"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1683708"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17468747"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19059915"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19204296"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1975028"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19923577"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19927125"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19936054"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20375014"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20564047"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21153684"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2564168"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26061765"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2783132"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7485229"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7699395"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7783876"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7902693"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7902972"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7906019"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7913755"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8105771"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8461023"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8797472"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8909447"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9266722"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9384372"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9482303"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9786248"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9792871"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000305"/>
<evidence key="65" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11900542"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21478263"/>
</source>
</evidence>
<sequence length="253" mass="27661" checksum="43DB596BAAA66484" modified="1986-11-01" version="1" precursor="true">
MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQP
HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA
VVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV
NITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPV
ILLISFLIFLIVG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>